Related by context. All words. (Click for frequent words.) 76 nanoviricide drug 75 NEUGENE 75 nanoviricide 75 FluCide 73 DermaVir 72 Thiovir 72 influenza VLP vaccine 71 NEUGENE antisense 70 radezolid 70 MVA BN R 70 Onconase 70 preclinically 69 prophylactic vaccine 69 PEGylated 69 delafloxacin 69 cancer immunotherapies 69 siRNA therapeutic 68 VLP vaccine 68 Tarvacin Anti Viral 68 Radilex 68 mAbs 68 humanized antibodies 68 Tarvacin TM 68 RhuDex ® 68 polymerase inhibitors 68 EKC Cide 68 Anticalins 68 attenuated strain 68 Valortim R 67 Interferon alpha 67 Tarvacin 67 XmAb# 67 proteasome inhibitor 67 Valortim ® 67 CBLC# 67 antiviral compounds 67 CCR5 antagonist 67 DOS# 67 therapeutic monoclonal antibodies 67 subunit vaccine 67 Ampligen ® 67 recombinant antibodies 67 NanoViricides 67 immunomodulatory 67 OMP #M# 67 Vaxfectin 66 DermaVir Patch 66 CD# antibodies 66 peptide antigens 66 humanized monoclonal antibodies 66 Sphingomab 66 ENMD # 66 torezolid 66 OncoVEX 66 BioVant 66 siRNA therapeutics 66 Nanobodies 66 GRNVAC1 66 pDNA vaccines 66 Guanilib 66 Symadex 66 oncolytic 66 oral prodrug 66 NITD# 66 tetravalent vaccine 66 AEG# 66 preclinical efficacy 66 Anidulafungin 66 Traficet EN 66 replicon 66 antibody fragment 65 oral antiviral 65 OHR/AVR# 65 antisense compounds 65 Marburg viruses 65 tigecycline 65 HCV protease inhibitors 65 humanized antibody 65 TPI ASM8 65 MEK inhibitors 65 Anticalins ® 65 VLPs 65 Multimeric 65 neuraminidase inhibitor 65 retapamulin 65 AdVac ® 65 lentiviral vector 65 TG# [003] 65 hemorrhagic fever viruses 65 H#N# VLP vaccine 65 NS#/#A protease 65 indibulin 65 therapeutic monoclonal antibody 65 GAP #B# 65 Sym# 65 LEAPS TM 65 solithromycin 65 Viprovex TM 65 NXL# 65 Cytolin R 65 immunotoxins 65 Panzem 65 influenza subtypes 65 NovaBay Aganocide compounds 65 Radezolid 65 MAbs 64 Neugene 64 Vaxfectin R adjuvant 64 nucleoside analogues 64 IMA# 64 DiLA2 64 silico prediction 64 orally dosed 64 proteasome inhibitors 64 Ramoplanin 64 favorable pharmacokinetic profile 64 Chimigen 64 NEUGENE R 64 bactericidal activity 64 histone deacetylase HDAC 64 GLP toxicology studies 64 mertansine 64 anti CD3 monoclonal 64 Alferon N 64 oncolytic virus 64 CDDO Im 64 EndoTAG TM -1 64 antiviral therapies 64 DNA plasmids 64 VDAs 64 SynCon 64 VLP vaccines 64 molecularly targeted 64 MVA BN ® 64 Altastaph 64 fusion inhibitor 64 BAL# [001] 64 selective orally bioavailable 64 PROCHYMAL 64 Nanobody 64 SynCon TM DNA 64 CEQ# 64 Anthim 64 Phylomer ® 64 PEG SN# 64 Cytolin ® 64 cytotoxin 64 amikacin 64 HCV protease 64 daptomycin 64 TLR9 agonist 64 OncoVEX GM CSF 64 Anticalin ® 64 CCX# 64 TRIOLEX 64 ESBA# 64 exon skipping 64 XmAb 63 Xanafide 63 recombinant subunit vaccine 63 particle VLP vaccine 63 immunotherapeutic 63 lipid nanoparticle 63 viral hemorrhagic fevers 63 HQK 63 AVI NEUGENE 63 BAL# [002] 63 small molecule defensin 63 HTS assay 63 pexiganan 63 immunotherapeutics 63 Cardio Vascu Grow 63 immune stimulatory 63 Ebola Marburg 63 orally bioavailable 63 HCV replicon 63 Delafloxacin 63 antiviral efficacy 63 JAK inhibitors 63 dengue viruses 63 CG# [003] 63 DXL# 63 Factor VIIa 63 REMUNE R 63 polyclonal 63 antisense drug 63 prostone 63 DAS# [001] 63 Locked Nucleic Acid LNA 63 Carfilzomib 63 antiangiogenesis 63 Hemopurifier 63 SERMs 63 SynCon ™ DNA 63 NOD mouse 63 S/GSK# 63 virotherapy 63 HuLuc# 63 monoclonals 63 huC# DM4 63 cMET 63 cidofovir 63 adenoviral 63 ATL# [001] 63 A3 adenosine receptor 63 PORxin TM 63 pharmacodynamic properties 63 IAP inhibitors 63 ROTARIX 63 flavopiridol 63 Valortim 63 isotypes 63 Universal Flu Vaccine 63 recombinant adeno associated 63 Ceftaroline 63 ocular formulation 63 biologic therapeutics 63 LNP formulations 63 CRLX# 63 protein kinase inhibitor 63 plasmid DNA vaccine 63 immune modulating 63 vidofludimus 63 AAV vector 63 Zysolin TM 63 Homspera 63 milatuzumab 63 UsiRNAs 63 theranostic 63 viral genomes 63 transfection reagents 63 tubulin inhibitor 63 vascular disrupting agents 63 personalized immunotherapy 63 siRNA sequences 63 SinuNase TM 63 recombinants 62 xTAG RVP 62 neutralizing antibody 62 elvucitabine 62 thymalfasin 62 IRX 2 62 fusion proteins 62 anti CD3 62 novel peptide 62 Tarmogen 62 Cethromycin 62 JAK inhibitor 62 RNA antagonist 62 Onalta ™ 62 biodefense countermeasure 62 SNALP technology 62 TLR agonists 62 enveloped viruses 62 capsular polysaccharide 62 dermatophyte 62 BRAF inhibitors 62 synthetic peptides 62 INT# [002] 62 NEUMUNE 62 immunotoxin 62 preclinical studies 62 mAb 62 prodrugs 62 Antigenics QS 62 prophylactic vaccines 62 TAKSTA 62 Fodosine 62 PSMA ADC 62 monoclonal antibody mAb 62 Lpathomab 62 immunomodulator 62 EGFR antibodies 62 nanomedicines 62 recombinant vaccine 62 anticoagulant reversing agent 62 CCR5 inhibitor 62 anti CD# antibodies 62 BiTE 62 Psoraxine R 62 vivo efficacy 62 busulfan 62 DepoVax TM 62 Nanoviricides 62 humanized monoclonal 62 Hedgehog inhibitor 62 transfection reagent 62 fluoroquinolone antibiotic 62 multivalent vaccine 62 liposomal formulation 62 Amplimexon 62 recombinant vaccines 62 NNRTIs 62 CD# CEA 62 Archexin 62 RAV# 62 triphendiol 62 polyclonal antibodies 62 nanoviricides ® 62 ALN TTR 62 Panzem R NCD 62 Angiolix 62 beta lactams 62 lipopeptide 62 ImQuest 62 OXi# 62 attenuated vaccine 62 Nanobody ® 62 immunomodulatory properties 62 virosome 62 HCV protease inhibitor 62 Vidofludimus 62 bivalent vaccine 62 virosomes 62 cyclophilin inhibitors 62 Nanobodies ® 62 RenaZorb TM 62 tkRNAi 62 echinocandins 62 lentiviral vectors 62 PDE4 inhibitor 62 Kevetrin 62 chemotherapeutic drug 62 inhibit metastasis 62 Anticalins R 62 Phase Ib study 62 Curaxin 62 beta lactamase inhibitor 62 JAK2 inhibitor 62 vitro studies 62 LT NS# 62 Replikins 62 Cerashield 62 Reverset 62 Vacc 4x 62 Cytolin 62 nucleoside 62 alpha interferon 62 ATL# [002] 62 Aganocide ® 62 Transfection Reagent 62 butyrylcholinesterase 62 Hemopurifier TM 62 splice variants 62 non nucleoside 61 MEK inhibitor 61 LEX System 61 TCAD therapy 61 lipid nanoparticle LNP 61 monoclonal antibodies 61 RNAi therapeutic targeting 61 antiviral therapeutics 61 Neutralizing antibodies 61 Dalbavancin 61 antimicrobial compounds 61 vaccine adjuvant 61 immune modulatory 61 anti infective treatments 61 deacetylase inhibitors 61 monoclonal 61 fluconazole resistant 61 Chimigen TM 61 Protectan CBLB# 61 pomalidomide 61 HBV vaccine 61 immunomodulators 61 anticancer compounds 61 mucosal vaccines 61 Solazed TM 61 Belerofon 61 adenoviral vectors 61 GeoVax vaccine 61 novel anticancer 61 predictive biomarkers 61 nanoparticle formulation 61 vascular disrupting agent 61 Xencor XmAb 61 quinolone 61 VivaGel TM 61 multitargeted 61 nucleoside analog 61 trastuzumab DM1 T DM1 61 Fludase 61 Aviptadil 61 Protexia R 61 antigen sparing 61 TAT# 61 VRX# [001] 61 antitumoral 61 Phase IIb clinical trials 61 ESBLs 61 SNALP 61 MAb 61 Alinia 61 systemically administered 61 REP# 61 vitro experiments 61 talabostat 61 TransVax tm 61 Vaxfectin ® 61 Trofex TM 61 Monoclonal 61 Annexin V 61 cleavable linker 61 CCR5 inhibitors 61 receptor tyrosine kinase inhibitor 61 liposomal 61 drug ISA# 61 ATL/TV# 61 Novosom 61 adenovirus vector 61 antisense oligonucleotides 61 Ampligen R 61 YONDELIS 61 Tekmira SNALP technology 61 CGEN # 61 histone deacetylase inhibitor 61 CR# vcMMAE 61 Elvitegravir 61 RiVax 61 xenograft models 61 Azedra 61 C. difficile toxins 61 BACcel 61 GelVac TM 61 Therapeutic Vaccine 61 Allovectin 7 R 61 intravesical instillation 61 LC#m# 61 iSONEP 61 JAK1 61 non nucleoside inhibitor 61 Pradefovir 61 ganetespib 61 Pertuzumab 61 paramyxoviruses 61 RNAi therapeutic 61 epigenetic therapies 61 oncolytic viruses 61 targeting CD# 61 inactivated vaccine 61 eTag assays 61 Cyclosert 61 Nektar proprietary 61 Cathepsin S 61 thiazolides 61 RGB # 61 viral pathogens 61 adenovector 61 rxRNA compounds 61 proprietary PEGylation 61 ganciclovir 61 investigational humanized monoclonal antibody 61 PI3K inhibitor 61 Aganocide 61 synDNA TM 61 tolevamer 61 outer membrane proteins 61 rilonacept 61 rxRNA 61 transgenic mouse models 61 maturation inhibitor 61 Zalypsis 61 induces antibodies 61 CCR5 antagonists 61 stable nucleic acid 61 biodefense pathogens 61 Excellarate 61 renin inhibitors 61 Vaxfectin adjuvant 61 molecular assays 61 HIV protease 61 nanomolar 61 HDACi 61 ZFN modified 61 itraconazole Sporanox 61 anticancer agent 61 ALN TTR# 61 DepoVax 61 Pimavanserin 61 TBC M4 61 affinity antibodies 61 MVA BN 61 radiolabeled monoclonal antibody 61 Phylomer 61 OxBC 61 pharmacodynamic markers 61 cannabinor 61 CD# monoclonal antibody 61 DepoVax ™ 61 CYT# 61 Vaccine Candidate 61 HIV integrase inhibitors 60 AMPK activators 60 virulence genes 60 paclitaxel Taxol 60 IgM antibody 60 EZN 60 Tezampanel 60 antigenicity 60 ZFP Therapeutic 60 using Crucell PER.C6 60 BHT DNA 60 p# antigen 60 DispersinB ® 60 antiviral activity 60 Aurora kinase inhibitors 60 Bavituximab 60 BCR ABL inhibitors 60 non nucleoside HCV 60 ETEC vaccine 60 cytoprotective 60 PXD# 60 preclinical 60 proprietary LNA 60 GelSite polymer 60 VRX# [002] 60 beta lactam antibiotics 60 CA4P 60 RhuDex R 60 integrase inhibitor 60 glycosylation profile 60 Mpex 60 Tyrima 60 immunized mice 60 Gleevec resistant 60 Sinovac vaccine 60 monoclonal antibody 60 Nestorone 60 HyACT 60 Shigamabs ® 60 Squalamine 60 RECOTHROM R 60 Scancell 60 DAVANAT 60 DHFR 60 orally administered inhibitor 60 miRview mets 60 filoviruses 60 GRN#L 60 Human cl 60 torezolid phosphate 60 potent cytotoxic 60 bioactive lipids 60 mda 7 60 NexACT 60 topical microbicides 60 Oritavancin 60 HuMax CD# 60 cytotoxic T lymphocyte 60 TransVax TM 60 Anavex #-# 60 Alocrest 60 DermaPrep 60 hemorrhagic fever virus 60 immatics 60 nanopharmaceutical 60 Zap CHO 60 anti amnesic 60 live attenuated vaccines 60 Epothilones 60 Onalta TM 60 subunit vaccines 60 Exherin TM 60 T#I [002] 60 VitiGam 60 recombinant polyclonal antibody 60 TKM ApoB 60 quinolone antibiotic 60 TLR antagonists 60 lentiviral 60 Citroxin 60 recombinant protein 60 Maribavir 60 Zolinza 60 targeted radiotherapeutic 60 MET amplification 60 enzyme inhibitor 60 nitazoxanide 60 anticancer therapies 60 nucleoside analogs 60 CYC# 60 LY# [003] 60 synthetic siRNAs 60 Simian Immunodeficiency Virus 60 Tesetaxel 60 Aganocide R 60 Azedra ™ 60 ELISA kit 60 LPA1 receptor 60 vitro assay 60 JAK3 60 highly pathogenic strains 60 DB# [003] 60 Preclinical studies suggest 60 AtuRNAi 60 Chlamydia trachomatis 60 THR beta agonist 60 Anticalin R 60 polyclonal antibody 60 Telatinib 60 Chemokine Receptor 60 CORT # 60 Alfacell proprietary ribonuclease 60 topical microbicide 60 rifamycins 60 atacicept 60 ChronVac C ® 60 NP2 Enkephalin 60 therapeutic antibody 60 TBC# 60 Intercell vaccine 60 human microdosing 60 Alferon LDO 60 Vaxfectin TM adjuvant 60 Sphingomab TM 60 humanized monoclonal antibody 60 CXCR4 receptor 60 telomerase activators 60 TTR gene 60 rifalazil 60 nucleoside reverse transcriptase inhibitor 60 VAX# 60 TLR9 agonists 60 Candida species 60 BACcel ™ system 60 SinuNase ™ 60 HSP# inhibitor 60 pegylated 60 AMN# [001] 60 inhibit replication 60 Cardiotoxicity 60 mapatumumab 60 Spectral EAA TM 60 HuCAL PLATINUM 60 volociximab 60 interferon lambda 60 immunostimulatory 60 bispecific antibody 60 radionuclide therapy 60 TKB# 60 telaprevir VX 60 Captisol Enabled 60 Lodamin 60 immunogens 60 selective immunoproteasome inhibitor 60 NS4A 60 pradefovir 60 anticancer compound 60 hybridoma 60 FluChip 60 hMPV 60 dermatophytes 60 novel VDA molecule 60 Cempra 60 Vaxfectin TM 60 rxRNA TM compounds 60 Th2 cytokines 60 polymerase inhibitor 60 Darinaparsin 60 nonclinical studies 60 Qdot 60 Novavax trivalent seasonal influenza 60 PSN# [002] 60 monoclonal antibodies MAbs 60 OXIGON TM 60 IMPDH 60 Litx 60 PREVENAR 60 HCV antiviral 60 highly immunogenic 60 azoles 60 PNT# 60 serum antibody 60 TLR8 60 ART# 60 MMP inhibitors 60 vivo validation 60 Telbivudine 60 benzimidazole 60 rBChE 60 antagomirs 60 ALK inhibitors 60 cetuximab Erbitux ® 60 AAV vectors 60 ELISPOT assay 60 PEGylated interferon 60 polyketides 60 humanized anti 60 TRO# 60 JVRS 60 macrolide antibiotic 60 Viral Immunotherapy platform 60 ChimeriVax JE 60 nucleotide analog 60 intradermal injection 60 histone deacetylase inhibitors 60 monoclonal antibody MAb 60 anionic backbone 60 ceftazidime 60 murine monoclonal antibody 60 OTC BB NNVC.OB 60 AVP #D# 60 #ME# 60 anidulafungin 60 HCV polymerase inhibitors 60 Civacir 60 GFT# 60 reverse vaccinology 60 ANAVEX #-# [001] 60 antiproliferative effects 60 PI3K/mTOR 60 virus AAV 60 Japanese Encephalitis vaccine 60 VeraTag 60 antisense drugs 60 ProLindac 60 imatinib Gleevec 60 Dicer Substrate Technology 60 botulinum neurotoxin 60 dAbs 60 Novavax VLP 59 IgG1 antibody 59 isoform selective 59 M2e 59 elotuzumab 59 FGFR 59 ApoB SNALP 59 ALN VSP 59 antisense inhibitors 59 virosome technology 59 Angiocept 59 topical antimicrobial 59 PCR assay 59 viral isolates 59 IgG antibodies 59 PEGPH# 59 synergistic combinations 59 Spiegelmer ® 59 FluCide HP 59 Escherichia coli O# 59 Pegylated 59 bioscavenger 59 CRD5 59 TELINTRA 59 ActA 59 investigational protease inhibitor 59 zileuton 59 topical formulations 59 Bezielle 59 oral JAK1 59 IL# PE 59 huN# DM1 59 tkRNAi technology 59 depsipeptide 59 DispersinB R 59 CTAP# Capsules 59 Personalized Immunotherapy 59 HepeX B 59 davunetide intranasal AL 59 pharmacodynamic biomarkers 59 vascular disrupting 59 Nitazoxanide 59 Dasatinib 59 GW# [003] 59 GelSite R polymer 59 PER.C6 ® 59 EV# vaccine 59 nasal powder 59 phage display 59 Intravenous CP 59 anticancer activity 59 neuraminidase inhibitors 59 obatoclax 59 macrolide antibiotics 59 potently inhibit 59 Dacogen decitabine 59 ceftaroline 59 preclinical toxicology 59 ZFP TF 59 selective adenosine 59 Lovaxin C 59 antiviral potency 59 beta lactam antibiotic 59 S. maltophilia 59 drug conjugates ADCs 59 riociguat 59 Brucella abortus 59 arenaviruses 59 QbG# 59 kinase inhibition 59 PI3K inhibitors 59 tumor xenograft models 59 NPC 1C 59 PCV2 59 S. pyogenes 59 pneumococcal serotypes 59 potent anti angiogenic 59 ImmunoVEX HSV2 59 tipranavir 59 interferon IFN 59 Modified Vaccinia Ankara MVA 59 Recombinant Human 59 MCSP respectively 59 Viprovex R 59 ASONEP 59 cephalosporin antibiotics 59 trabectedin 59 Viprovex 59 multiplex assay 59 therapeutic mAbs 59 NRTI resistance 59 griseofulvin 59 patented Bioral 59 #D#C# 59 ProNAi 59 VEGF inhibitors 59 transgenic rats 59 N. gonorrhoeae 59 immunological responses 59 nonviral 59 Panzem R 59 thalidomide Thalomid 59 nucleotide analogs 59 GPCR targets 59 AzaSite Plus 59 recombinant 59 FluINsure 59 Phase #b/#a trial 59 VA# [002] 59 probiotic strains 59 AFFITOME R 59 POTELLIGENT ® 59 Tarceva TM 59 adipiplon 59 small molecule inhibitors 59 microRNA biomarkers 59 ONCONASE R 59 JAK2 inhibitors 59 tetravalent 59 imatinib Gleevec ® 59 immuno therapeutic 59 Aflibercept 59 rifamycin 59 PrevOnco 59 MyVax R 59 Interferon Beta 59 Onalta 59 receptor inhibitor 59 DXL TM 59 immunotherapeutic vaccine 59 CMV vaccine 59 bovine thrombin 59 vivo potency 59 rPA anthrax vaccine 59 uricase 59 Fleximer 59 annexin V 59 SCIB1 59 Aptamer 59 calcineurin inhibitors 59 rhIL 7 59 systemic RNAi 59 HE# [002] 59 Afatinib 59 anti idiotype 59 intranasal delivery 59 DCVax R 59 molecular biomarkers 59 DXL ™ 59 INGN 59 ketolide antibiotic 59 anticancer therapeutics 59 epithelial tumors 59 AFFiRiS 59 PD LID 59 MAGE A3 ASCI 59 SAR# [002] 59 fusidic acid 59 cariprazine 59 Chemophase 59 TRV# [001] 59 Pandemic Influenza Vaccine 59 murine models 59 MT#/MEDI-# 59 IFN alpha 59 Eraxis 59 intranasal formulation 59 immune modulators 59 antiangiogenic agents 59 OXIGON 59 Olaparib 59 nanobodies 59 TAFA# 59 PRTX 59 P. falciparum parasites 59 brostallicin 59 antifolates 59 Anticalin 59 Oncolytic 59 immunomodulation 59 FLU v 59 CYT# potent vascular disrupting 59 mimetics 59 ZK EPO 59 NOX E# 59 Bioral 59 viral kinetics 59 Etubics 59 ANAVEX #-# [003] 59 immunotherapies 59 EndoTAG TM 59 Streptomycin 59 CCR9 59 Actilon 59 SPC# [001] 59 DiLA2 Platform 59 anti secretory 59 PGL# 59 histone deacetylase HDAC inhibitor 59 ulimorelin 59 immunoconjugate 59 HCV NS3 protease 59 synthetic retinoid 59 vinca alkaloid 59 selective inhibition 59 GHRH 59 clade B 59 Cylene 59 kinase inhibitors 59 inhibitor RG# 59 tanespimycin 59 virulent pathogens 59 AAG geldanamycin analog 59 antitumor effect 59 glycosylated 59 GSK# [002] 59 PRT# 59 reslizumab 59 DPX Survivac 59 neuroprotective properties 59 NuroPro ® 59 SynCon TM 59 topical ophthalmic 59 chemokine receptors 59 HCV infections 59 SMT C# 59 dependent cellular cytotoxicity 59 cancer immunotherapy 59 MAbs targeting 59 NTDDS 59 YONDELIS R 59 conserved antigens NP 59 ANG# 59 MediVas 59 XmAb ™ 59 ARIKACE 59 meropenem 59 pafuramidine 59 trivalent influenza vaccine 59 SMaRT ™ 59 compound AEZS 59 SCH # 59 Bt toxins 59 HIV protease inhibitors 59 G#DT 59 F. tularensis 59 Liposomal 59 Antisense 59 pan HDAC inhibitor 59 TOCOSOL Camptothecin 59 SMARTICLES 59 radiation sensitizer 59 zidovudine AZT 59 protein antigens 59 Kahalalide F 59 UPLYSO 59 Dapagliflozin 59 IMP# 59 budesonide foam 59 Ganciclovir 59 therapeutic regimens 59 otelixizumab 59 ZFN technology 59 delipidation 59 infected macrophages 59 T#I mutant 59 Monoclonal Antibody 59 epothilones 59 INCB# [001] 59 IgG1 59 Trofex 59 potent antiviral 59 Atiprimod 59 AMD# [003] 59 lipid nanoparticles 59 Clevudine 59 IRHs 59 EndoTAG